Back to ACAD
HUSSMAN STRATEGIC ADVISORS, INC. → ACAD
HUSSMAN STRATEGIC ADVISORS, INC. ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$2.1M
Q3 2026
Peak value
$3.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.7M |
| Q4 2025 | $3.9M |
| Q1 2026 | $3.7M |
| Q2 2026 | $1.6M |
| Q3 2026 | $2.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.1M | 105.0K | — | — |
| Q2 2026 | $1.6M | 63.0K | — | — |
| Q1 2026 | $3.7M | 168.0K | — | — |
| Q4 2025 | $3.9M | 147.0K | — | — |
| Q3 2025 | $2.7M | 126.0K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M